120
Views
0
CrossRef citations to date
0
Altmetric
Review

The Neuro-Ophthalmology of Tuberculosis

, , , , &
Pages 73-92 | Received 27 Jul 2023, Accepted 26 Oct 2023, Published online: 27 Nov 2023

References

  • Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, Soriano-Moreno DR, Pacheco-Barrios K. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol. 2022;269(7):3482–3494. doi:10.1007/s00415-022-11052-8.
  • Modi M, Goyal M, Jain A, et al. Tuberculous meningitis: challenges in diagnosis and management: lessons learnt from Prof. Dastur’s article published in 1970. Neurol India. 2018;66(6):1550–1571. doi:10.4103/0028-3886.246224.
  • Saylor D. Neurologic complications of tuberculosis. Continuum (Minneap Minn). 2021;27(4):992–1017. doi:10.1212/CON.0000000000001005.
  • Dhiman R, Lakra S, Panda PK, Hemachandran N, Sharma S, Saxena R. Neuro-ophthalmic manifestations of tuberculosis. Eye (Lond). 2022;36(1):15–28. doi:10.1038/s41433-021-01619-6.
  • Modi M, Sharma K, Prabhakar S, et al. Clinical and radiological predictors of outcome in tubercular meningitis: a prospective study of 209 patients. Clin Neurol Neurosurg. 2017;161:29–34. doi:10.1016/j.clineuro.2017.08.006.
  • Sinha MK, Garg RK, Anuradha H, et al. Vision impairment in tuberculous meningitis: predictors and prognosis. J Neurol Sci. 2010;290(1–2):27–32. doi:10.1016/j.jns.2009.12.012.
  • Rajshekhar V. Management of hydrocephalus in patients with tuberculous meningitis. Neurol India. 2009;57(4):368–374. doi:10.4103/0028-3886.55572.
  • Lorber J. Studies of the cerebrospinal fluid circulation in tuberculous meningitis in children. Part II. A review of 100 pneumoencephalograms. Arch Dis Child. 1951;26(125):28–44. doi:10.1136/adc.26.125.28.
  • Zuhaimy H, Leow SN, Vasudevan SK. Optic disc swelling in a patient with tuberculous meningitis: a diagnostic challenge. BMJ Case Rep. 2017;2017:bcr-2017–221170. doi:10.1136/bcr-2017-221170.
  • Raut T, Garg RK, Jain A, et al. Hydrocephalus in tuberculous meningitis: incidence, its predictive factors and impact on the prognosis. J Infect. 2013;66(4):330–337. doi:10.1016/j.jinf.2012.12.009.
  • Testi I, Agrawal R, Mehta S, et al. Ocular tuberculosis: where are we today? Indian J Ophthalmol. 2020;68(9):1808–1817. doi:10.4103/ijo.IJO_1451_20.
  • Davis EJ, Rathinam SR, Okada AA, et al. Clinical spectrum of tuberculous optic neuropathy. J Ophthal Inflamm Infect. 2012;2(4):183–189. doi:10.1007/s12348-012-0079-5.
  • Gupta A, Goyal M, Modi M, Lal V. Tuberculous optic neuritis: a case report. J Neurol Sci. 2015;352(1–2):120–121. doi:10.1016/j.jns.2015.03.028.
  • Narayanan S, Prakash D, Subramaniam G. Bilateral primary optic neuropathy as the presenting manifestation of tuberculosis in an immunocompetent patient. IDCases. 2019;18:e00579. doi:10.1016/j.idcr.2019.e00579.
  • Ryu WY, Kim JS. Optic perineuritis simultaneously associated with active pulmonary tuberculosis without intraocular tuberculosis. Int J Ophthalmol. 2017;10(9):1477–1478. doi:10.18240/ijo.2017.09.23.
  • Purvin V, Kawasaki A, Jacobson DM. Optic perineuritis: clinical and radiographic features. Arch Ophthalmol. 2001;119(9):1299–1306. doi:10.1001/archopht.119.9.1299.
  • Kaur P, Takkar A, Kathirvel S, et al. Incidence of mitochondrial mutations in cohort of patients with ethambutol-induced optic neuropathy. J Neurol Sci. 2021;429:118470. doi:10.1016/j.jns.2021.118470.
  • Sharma P, Sharma R. Toxic optic neuropathy. Indian J Ophthalmol. 2011;59(2):137–141. doi:10.4103/0301-4738.77035.
  • Chamberlain PD, Sadaka A, Berry S, Lee AG. Ethambutol optic neuropathy. Curr Opin Ophthalmol. 2017;28(6):545–551. doi:10.1097/ICU.0000000000000416.
  • Menon V, Jain D, Saxena R, Sood R. Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol. 2009;93(9):1251–1254. doi:10.1136/bjo.2008.148502.
  • Kass I, Mandel W, Cohen H, Dressler SH. Isoniazid as a cause of optic neuritis and atrophy. JAMA. 1957;164(16):1740–1743. doi:10.1001/jama.1957.02980160012003.
  • Sotgiu G, Centis R, D’Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J. 2012;40(6):1430–1442. doi:10.1183/09031936.00022912.
  • Aljebreen MA, Alotaibi AK, Alrobaian M. Linezolid-induced toxic optic neuropathy. Middle East Afr J Ophthalmol. 2020;27(4):235–237. doi:10.4103/meajo.MEAJO_73_20.
  • Lee S, Kang BH, Ryu WY, Um SJ, Roh MS, Son C. Is severe and long-lasting linezolid-induced optic neuropathy reversible? Intern Med. 2018;57(24):3611–3613. doi:10.2169/internalmedicine.1344-18.
  • Das S, Mondal S. Oral levofloxacin-induced optic neuritis progressing in loss of vision. Ther Drug Monit. 2012;34(2):124–125. doi:10.1097/FTD.0b013e3182480af4.
  • Yuhl ET, Rand CW. Tuberculous opticochiasmatic arachnoiditis; report of a case. J Neurosurg. 1951;8(4):441–443. doi:10.3171/jns.1951.8.4.0441.
  • Davis AG, Rohlwink UK, Proust A, Figaji AA, Wilkinson RJ. The pathogenesis of tuberculous meningitis. J Leukoc Biol. 2019;105(2):267–280. doi:10.1002/JLB.MR0318-102R.
  • Singh AK, Malhotra HS, Garg RK, Jain A, Kumar N, Kohli N, et al. Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis. BMC Infect Dis. 2016;16(1):306. doi:10.1186/s12879-016-1625-9.
  • Garg RK, Paliwal V, Malhotra HS. Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis. Expert Rev Anti Infect Ther. 2011;9(9):719–729. doi:10.1586/eri.11.93.
  • Thuong NTT, Thwaites GE. Treatment-associated inflammatory deterioration in tuberculous meningitis: unpicking the paradox. J Infect Dis. 2017;215(5):665–667. doi:10.1093/infdis/jiw565.
  • Brown CS, Smith CJ, Breen RA, et al. Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study. BMC Infect Dis. 2016;16(1):479. doi:10.1186/s12879-016-1816-4.
  • Wisoff HS, Sarwar M. Chiasmal compression caused by a dilated third ventricle. Neuroradiology. 1975;8(4):195–199. doi:10.1007/BF00337651.
  • Garg RK, Malhotra HS, Kumar N, Uniyal R. Vision loss in tuberculous meningitis. J Neurol Sci. 2017;375:27–34. doi:10.1016/j.jns.2017.01.031.
  • Ma H, Liu Y, Zhuang C, Shen Y, Wu R. Clinical features and MRI findings of intracranial tuberculomas. Radiol Infect Dis. 2018;5(4):154–159. doi:10.1016/j.jrid.2018.10.001.
  • Schlernitzauer DA, Hodges FJ III, Bagan M. Tuberculoma of the left optic nerve and chiasm. Arch Ophthalmol. 1971;85(1):75–78. doi:10.1001/archopht.1971.00990050077011.
  • Takkar A, Mahesh KV, Shree R, Sachdeva J, Mehta S, Lal V. Tuberculomas in “critical” locations of the visual pathway-a masquerader. Neuroophthalmology. 2018;42(2):109–111. doi:10.1080/01658107.2017.1344866.
  • Parry AH, Wani AH, Shaheen FA, Wani AA, Feroz I, Ilyas M. Evaluation of intracranial tuberculomas using diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS) and susceptibility weighted imaging (SWI). Br J Radiol. 2018;91(1091):20180342. doi:10.1259/bjr.20180342.
  • Werring DJ, Marsden CD. Visual hallucinations and palinopsia due to an occipital lobe tuberculoma. J Neurol Neurosurg Psychiatry. 1999;66(5):684. doi:10.1136/jnnp.66.5.684.
  • Ortiz A, Cárdenas PL, Arana R, Gomez LM, Peralta M. Neuro-ophthalmological findings as first manifestation of occipital tuberculoma. Neuroophthalmology. 2021;45(2):120–125. doi:10.1080/01658107.2020.1771740.
  • Shree R, Mahesh KV, Balaini N, Goel A. Oculomotor cranial neuropathies: diagnosis and management. Ann Indian Acad Neurol. 2022;25(Suppl 2):S70–s82. doi:10.4103/aian.aian_167_22.
  • Saxena R, Menon V, Sinha A, Sharma P, Kumar DA, Sethi H. Pontine tuberculoma presenting with horizontal gaze palsy. J Neuroophthalmol. 2006;26(4):276–278. doi:10.1097/01.wno.0000249321.34733.59.
  • Menon V, Gogoi M, Saxena R, Singh S, Kumar A. Isolated “one and a half syndrome” with brainstem tuberculoma. Indian J Pediatr. 2004;71(5):469–471. doi:10.1007/BF02725645.
  • Gautam P, Sharma N. Isolated pontine tuberculoma presenting as horizontal gaze palsy. Indian Pediatr. 2015;52(2):166. doi:10.1007/s13312-015-0596-z.
  • Shao K, Dong F, Guo S, Wang J, Sun Z. Eight-and-a-half syndrome caused by tuberculous meningitis: a case report. Acta Neurol Belg. 2021;121(2):591–593. doi:10.1007/s13760-020-01536-7.
  • Enani M, Al-Nakhli DJ, Bakhsh E. Isolated brain stem tuberculoma presenting with one and a half syndrome. Saudi Med J. 2006;27:1407–1411.
  • Prabhat V, Vargaonkar GS, Mallojwar SR, Kumar R. Horner’s syndrome in cervico-dorsal tuberculosis: a rare case report. J Clin Orthop Trauma. 2017;8(2):171–173. doi:10.1016/j.jcot.2016.02.015.
  • Joo W, Yoshioka F, Funaki T, Rhoton AL Jr. Microsurgical anatomy of the abducens nerve. Clin Anat. 2012;25(8):1030–1042. doi:10.1002/ca.22047.
  • Dutta P, Nagpal V, Anand K, Mishra M. Bilateral oculomotor palsy in tuberculous rhomboencephalitis-a rare presentation. J Neurosci Rural Pract. 2021;12(1):217–218. doi:10.1055/s-0040-1721168.
  • Sharma K, Kanaujia V, Jaiswal S, et al. Brain stem tuberculoma presenting with isolated ocular motility abnormality: a series of two cases and review of literature. Oman J Ophthalmol. 2012;5(1):61–63. doi:10.4103/0974-620X.94782.
  • Kumar S, Rajshekher G, Prabhakar S. Isolated bilateral ptosis as the presentation of midbrain tuberculoma. Neurol India. 2008;56(2):212–213. doi:10.4103/0028-3886.42011.
  • Pradhan S, Das A, Mulmuley M, Das A. Neurocysticercosis or tuberculoma – which one has more epileptic potential? Seizure. 2020;78:91–95. doi:10.1016/j.seizure.2020.03.007.
  • Monga PK, Dhaliwal U. Paradoxical reaction in tubercular meningitis resulting in involvement of optic radiation. Indian J Ophthalmol. 2009;57(2):139–141. doi:10.4103/0301-4738.45504.
  • Devarbhavi H. Drug-induced liver injury unique to India. Clin Liver Dis (Hoboken). 2021;18(3):108–110. doi:10.1002/cld.1120.
  • Sharma K, Sharma M, Shree R, et al. Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: a diagnostic accuracy study from India. Tuberculosis (Edinb). 2020;125:101990. doi:10.1016/j.tube.2020.101990.
  • Meeting report of a technical expert consultation: noninferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF [Internet]. 2017. https://apps.who.int/iris/handle/10665/254792.Lic.
  • Ellis J, Cresswell FV, Rhein J, Ssebambulidde K, Boulware DR. Cryptococcal meningitis and tuberculous meningitis co-infection in HIV-infected Ugandan adults. Open Forum Infect Dis. 2018;5(8):ofy193. doi:10.1093/ofid/ofy193.
  • Jayasundar R, Singh VP, Raghunathan P, Jain K, Banerji AK. Inflammatory granulomas: evaluation with proton MRS. NMR Biomed. 1999;12(3):139–144. doi:10.1002/(SICI)1099-1492(199905)12:3<139:AID-NBM550>3.0.CO;2-H.
  • Han J, Byun MK, Lee J, Han SY, Lee JB, Han SH. Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2293–2299. doi:10.1007/s00417-015-3150-8.
  • Lee JY, Han J, Seo JG, Park KA, Oh SY. Diagnostic value of ganglion cell-inner plexiform layer for early detection of ethambutol-induced optic neuropathy. Br J Ophthalmol. 2019;103(3):379–384. doi:10.1136/bjophthalmol-2018-312063.
  • Jain A, Goyal MK, Mittal BR, et al. 18FDG-PET is sensitive tool for detection of extracranial tuberculous foci in central nervous system tuberculosis – preliminary observations from a tertiary care center in northern India. J Neurol Sci. 2020;409:116585. doi:10.1016/j.jns.2019.116585.
  • Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4(4):Cd002244. doi:10.1002/14651858.CD002244.pub4.
  • Critchley JA, Young F, Orton L, Garner P. Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):223–237. doi:10.1016/S1473-3099(12)70321-3.
  • Sharma S, Goyal MK, Sharma K, et al. Cytokines do play a role in pathogenesis of tuberculous meningitis: a prospective study from a tertiary care center in India. J Neurol Sci. 2017;379:131–136. doi:10.1016/j.jns.2017.06.001.
  • van Toorn R, Solomons RS, Seddon JA, Schoeman JF. Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort. Clin Infect Dis. 2021;72(5):e136–e45. doi:10.1093/cid/ciaa1826.
  • de la Riva P, Urtasun M, Castillo-Trivino T, et al. Clinical response to thalidomide in the treatment of intracranial tuberculomas: case report. Clin Neuropharmacol. 2013;36(2):70–72. doi:10.1097/WNF.0b013e318285caa1.
  • Schoeman JF, Fieggen G, Seller N, Mendelson M, Hartzenberg B. Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J Child Neurol. 2006;21(4):301–308. doi:10.1177/08830738060210040801.
  • Liu P, Pei N, Liu X, Huang W, Lu S. Thalidomide in the treatment of human immunodeficiency virus-negative tuberculous meningitis: a case report. Medicine. 2020;99(40):e22639. doi:10.1097/MD.0000000000022639.
  • Modi M, Shree R, Kakkar A, Goyal M, Sharma K. Role of thalidomide in the management of complicated tuberculous meningitis (S25.005). Neurology. 2023;100:2713.
  • Jorge JH, Graciela C, Pablo AP, Luis SH. A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis. J Clin Rheumatol. 2012;18(4):189–191. doi:10.1097/RHU.0b013e318258b725.
  • Blackmore TK, Manning L, Taylor WJ, Wallis RS. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis. 2008;47(10):e83–5. doi:10.1086/592695.
  • Marais BJ, Cheong E, Fernando S, et al. Use of infliximab to treat paradoxical tuberculous meningitis reactions. Open Forum Infect Dis. 2021;8(1):ofaa604. doi:10.1093/ofid/ofaa604.
  • Gonzalez-Duarte A, Higuera-Calleja J, Flores F, Davila-Maldonado L, Cantú-Brito C. Cyclophosphamide treatment for unrelenting CNS vasculitis secondary to tuberculous meningitis. Neurology. 2012;78(16):1277–1278. doi:10.1212/WNL.0b013e318250d84a.
  • Ledingham D, El-Walsh S, Sebire D, et al. Adjuvant immunosuppression for paradoxical deterioration in tuberculous meningitis including one case responsive to cyclosporine. A tertiary referral hospital experience. J Neurol Sci. 2019;404:58–62. doi:10.1016/j.jns.2019.07.002.
  • Domínguez-Moreno R, García-Grimshaw M, Medina-Julio D, Cantú-Brito C, González-Duarte A. Paradoxical manifestations during tuberculous meningitis treatment among HIV-negative patients: a retrospective descriptive study and literature review. Neurol Sci. 2022;43(4):2699–2708. doi:10.1007/s10072-021-05693-2.
  • Yang HK, Park MJ, Lee JH, Lee CT, Park JS, Hwang JM. Incidence of toxic optic neuropathy with low-dose ethambutol. Int J Tuberc Lung Dis. 2016;20(2):261–264. doi:10.5588/ijtld.15.0275.
  • Saxena R, Singh D, Phuljhele S, Kalaiselvan V, Karna S, Gandhi R, et al. Ethambutol toxicity: expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy. Indian J Ophthalmol. 2021;69(12):3734–3739. doi:10.4103/ijo.IJO_3746_20.
  • Rajshekhar V. Three decades of Vellore grading for tuberculous meningitis with hydrocephalus: a reappraisal. Neurol India. 2021;69(8):569–574. doi:10.4103/0028-3886.332251.
  • Yiek SH, Wong AS. Challenges and controversies in the management of tuberculous meningitis with hydrocephalus: a systematic review and Sarawak Institution’s experience. Asian J Neurosurg. 2022;17(2):189–198. doi:10.1055/s-0042-1750781.
  • Palur R, Rajshekhar V, Chandy MJ, Joseph T, Abraham J. Shunt surgery for hydrocephalus in tuberculous meningitis: a long-term follow-up study. J Neurosurg. 1991;74(1):64–69. doi:10.3171/jns.1991.74.1.0064.
  • Paliwal V, Garg R. Hydrocephalus in tuberculous meningitis - pearls and nuances. Neurol India. 2021;69(8):330–335. doi:10.4103/0028-3886.332275.
  • Yadav YR, Parihar V, Pande S, Namdev H, Agarwal M. Endoscopic third ventriculostomy. J Neurosci Rural Pract. 2012;3(2):163–173. doi:10.4103/0976-3147.98222.
  • Singh D, Sachdev V, Singh AK, Sinha S. Endoscopic third ventriculostomy in post-tubercular meningitic hydrocephalus: a preliminary report. Minim Invasive Neurosurg. 2005;48(1):47–52. doi:10.1055/s-2004-830183.
  • Husain M, Jha DK, Rastogi M, Husain N, Gupta RK. Role of neuroendoscopy in the management of patients with tuberculous meningitis hydrocephalus. Neurosurg Rev. 2005;28(4):278–283. doi:10.1007/s10143-005-0397-2.
  • Legaspi GD, Espiritu AI, Omar AT. Success and complication rates of endoscopic third ventriculostomy for tuberculous meningitis: a systematic review and meta-analysis. Neurosurg Rev. 2021;44(4):2201–2209. doi:10.1007/s10143-020-01396-y.
  • Yadav YR, Parihar VS, Todorov M, et al. Role of endoscopic third ventriculostomy in tuberculous meningitis with hydrocephalus. Asian J Neurosurg. 2016;11(4):325–329. doi:10.4103/1793-5482.145100.
  • Aranha A, Choudhary A, Bhaskar S, Gupta LN. A randomized study comparing endoscopic third ventriculostomy versus ventriculoperitoneal shunt in the management of hydrocephalus due to tuberculous meningitis. Asian J Neurosurg. 2018;13(4):1140–1147. doi:10.4103/ajns.AJNS_107_18.
  • Davis A, Meintjes G, Wilkinson RJ. Treatment of tuberculous meningitis and its complications in adults. Curr Treat Options Neurol. 2018;20(3):5. doi:10.1007/s11940-018-0490-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.